AOC3 is highly expressed in adipocytes and smooth muscle cells, but its function in these cells is currently unknown. The in vivo substrate(s) of AOC3 is/are also unknown, but could provide an invaluable clue to the enzyme's function. Expression of untagged, soluble human AOC3 in insect cells provides a relatively simple means of obtaining pure enzyme. Characterization of enzyme indicates a 6% titer for the active site 2,4,5-trihydroxyphenylalanine quinone (TPQ) cofactor and corrected kcat values as high as 7 s−1. Substrate kinetic profiling shows that the enzyme accepts a variety of primary amines with different chemical features, including nonphysiological branched-chain and aliphatic amines, with measured kcat/Km values between 102 and 104 M−1 s−1. Km(O2) approximates the partial pressure of oxygen found in the interstitial space. Comparison of the properties of purified murine to human enzyme indicates kcat/Km values that are within 3 to 4-fold, with the exception of methylamine and aminoacetone that are ca. 10-fold more active with human AOC3. With drug development efforts investigating AOC3 as an anti-inflammatory target, these studies suggest that caution is called for when screening the efficacy of inhibitors designed against human enzymes in non-transgenic mouse models. Differentiated murine 3T3-L1 adipocytes show a uniform distribution of AOC3 on the cell surface and whole cell Km values that are reasonably close to values measured using purified enzymes. The latter studies support a relevance of the kinetic parameters measured with isolated AOC3 variants to adipocyte function. From our studies, a number of possible substrates with relatively high kcat/Km have been discovered, including dopamine and cysteamine, which may implicate a role for adipocyte AOC3 in insulin-signaling and fatty acid metabolism, respectively. Finally, the demonstrated AOC3 turnover of primary amines that are non-native to human tissue suggests possible roles for the adipocyte enzyme in subcutaneous bacterial infiltration and obesity.
AOC3在脂肪细胞和平滑肌细胞中高度表达,但目前尚不清楚其在这些细胞中的功能。AOC3的体内底物也不清楚,但可能为该酶的功能提供宝贵的线索。在昆虫细胞中表达无标记的可溶性人AOC3为获得纯酶提供了相对简单的手段。酶的表征表明,活性位点2,4,5-三羟基苯丙
氨酸醌(TPQ)辅因子的滴度为6%,校正后的kcat值高达7 s-1。底物动力学分析表明,该酶可接受具有不同
化学特征的各种
伯胺,包括非生理性的支链和脂肪族胺,测得的kcat/Km值在102和104 M-1 s-1之间。Km(O2)近似于间隙空间中的氧分压。纯化的小鼠酶与人酶的性质比较表明,kcat/Km值在3到4倍之间,但甲基胺和
氨基
丙酮除外,它们在人AOC3中的活性大约高出10倍。在药物开发中,AOC3被研究为抗炎靶点,这些研究表明,在非转
基因小鼠模型中筛选针对人酶的
抑制剂的功效时,需要谨慎。分化的小鼠3T3-L1脂肪细胞显示AOC3在细胞表面和整个细胞上的分布均匀,且整个细胞的Km值与使用纯化酶